Predict your next investment

Venture Capital
medfinecapital.com

See what CB Insights has to offer

Investments

64

Funds

2

About Med-Fine Capital

Med-Fine Capital makes venture capital and private equity investments in the fields of biosciences and healthcare, particularly focusing on promising early-phase and growth-stage companies.

Med-Fine Capital Headquarter Location

Longhua Road 858, Building B, 7th Floor Huangpu District

Shanghai, Shanghai, 200023,

China

+86 021-63269680

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Med-Fine Capital News

Allorion Therapeutics Completes $40M Series A Financing Round

Nov 24, 2021

Allorion Therapeutics , a Boston, MA-based next-generation precision medicine company focused on oncology and autoimmune diseases, compled a $40M Series A financing. This round was led by Qiming Venture Partners with participation from IDG Capital, Octagon Capital, Firstred Capital, and Elikon Venture, as well as existing investors TF Capital and Med-Fine Capital. The company intends to use the funds to accelerate the advancement of preclinical projects, IND-enabling studies and IND applications of two drug candidates in China and the United States, to increase its investment in its platform technologies in the systematic screen for allosteric inhibitors and synthetic lethality targets with matching tool compounds, and to enhance the clinical and business development teams. Led by Peter Ding, Founder and CEO, Allorion leverages a drug discovery engine which integrates technological breakthroughs in protein structure, big data, machine learning and gene editing to systematically discover and develop highly selective small molecules, including covalent and allosteric inhibitors of well-validated targets. The company has also built a synthetic lethality screening platform to expand the scope of targeted therapies for cancer patients, laying a solid foundation for its long-term success. FinSMEs 24/11/2021

Med-Fine Capital Investments

64 Investments

Med-Fine Capital has made 64 investments. Their latest investment was in Ultrast as part of their Series A on April 4, 2022.

CBI Logo

Med-Fine Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/7/2022

Series A

Ultrast

No

2

2/28/2022

Seed VC

Wuxi Kejin Bio

$15.85M

Yes

3

1/13/2022

Seed VC - II

Westlake Omics

Yes

7

12/31/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

11/30/2021

Seed VC

Subscribe to see more

Subscribe to see more

10

Date

4/7/2022

2/28/2022

1/13/2022

12/31/2021

11/30/2021

Round

Series A

Seed VC

Seed VC - II

Series A

Seed VC

Company

Ultrast

Wuxi Kejin Bio

Westlake Omics

Subscribe to see more

Subscribe to see more

Amount

$15.85M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

3

7

10

10

Med-Fine Capital Fund History

2 Fund Histories

Med-Fine Capital has 2 funds, including 德州两仪幂方康健创业投资合伙企业 (Dezhou Liangyi Mifang Health Venture Capital Partnership).

Closing Date

Fund

Fund Type

Status

Amount

Sources

德州两仪幂方康健创业投资合伙企业 (Dezhou Liangyi Mifang Health Venture Capital Partnership)

苏州一元幂方医药创业投资合伙企业 (Suzhou Yiyuan Mifang Pharmaceutical Venture Capital Partnership)

0

Closing Date

Fund

德州两仪幂方康健创业投资合伙企业 (Dezhou Liangyi Mifang Health Venture Capital Partnership)

苏州一元幂方医药创业投资合伙企业 (Suzhou Yiyuan Mifang Pharmaceutical Venture Capital Partnership)

Fund Type

Status

Amount

Sources

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.